About Index Trending news
Analyze
Top 50 Pricing
Benevir Biopharm

Benevir Biopharm

Work at Benevir Biopharm? Add yourself to this profile

Benevir Biopharm

In the emerging field of oncolytic virotherapy, BeneVir is developing an improved therapeutic platform that can be adapted to target a wide variety of cancers.

Elsewhere

Alexa global traffic share

Twitter followers

16 Feb 2016
$3,000,000
Venture capital (Series Undisclosed)

SEC FORM D

sec
26 Nov 2014
$2,000,000
Venture capital